𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alzheimer Disease—No Target for Statin Treatment. A Mini Review

✍ Scribed by Siegfried Hoyer; Peter Riederer

Book ID
106483522
Publisher
Springer
Year
2006
Tongue
English
Weight
267 KB
Volume
32
Category
Article
ISSN
0364-3190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

β-secretase as a target for the treatmen
β-secretase as a target for the treatment of Alzheimer's disease
✍ Martin Citron 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 1 views

## Abstract Finding inhibitors of the first step of the amyloid cascade, Aβ~42~ generation, is a major goal of Alzheimer's disease drug development. Two target protease activities, β‐and γ‐secretase, were detected more than 10 years ago but progress in this area has been slow because the enzymes we

A review and commentary on a sample of 1
A review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease
✍ Richard J. Harvey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

Background. There has been widespread development of clinical guidelines for the treatment of Alzheimer's disease since the introduction of donepezil in the UK in 1997. These have been developed nationally, regionally, locally and by independent groups. An independent review of guidelines available